Needham & Company Reiterates Buy Rating, $84 PT on Pacira Pharmaceuticals (PCRX), Continue to Expect Significant Sales Growth Rebound

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/15/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. ADYYF
10. DVLT

Go back to Needham & Company Reiterates Buy Rating, $84 PT on Pacira Pharmaceuticals (PCRX), Continue to Expect Significant Sales Growth Rebound
PACIRA (NASDAQ: PCRX) Delayed: 23.00 -0.18 (0.78%)
Previous Close $23.18    52 Week High $80.25 
Open $23.21    52 Week Low $30.25 
Day High $23.37    P/E N/A 
Day Low $22.79    EPS $-2.08 
Volume 645,096